Emerging prospects of exosomes for cancer treatment: from conventional therapy to immunotherapy

GH Nam, Y Choi, GB Kim, S Kim, SA Kim… - Advanced …, 2020 - Wiley Online Library
Exosomes are a class of extracellular vesicles of around 100 nm in diameter that are
secreted by most cells and contain various bioactive molecules reflecting their cellular origin …

Myeloid immunosuppression and immune checkpoints in the tumor microenvironment

K Nakamura, MJ Smyth - Cellular & molecular immunology, 2020 - nature.com
Tumor-promoting inflammation and the avoidance of immune destruction are hallmarks of
cancer. While innate immune cells, such as neutrophils, monocytes, and macrophages, are …

CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy

AA Barkal, RE Brewer, M Markovic, M Kowarsky… - Nature, 2019 - nature.com
Ovarian cancer and triple-negative breast cancer are among the most lethal diseases
affecting women, with few targeted therapies and high rates of metastasis. Cancer cells are …

Emerging strategies in targeting tumor-resident myeloid cells for cancer immunotherapy

Y Wang, KCC Johnson, ME Gatti-Mays, Z Li - Journal of hematology & …, 2022 - Springer
Immune checkpoint inhibitors targeting programmed cell death protein 1, programmed death-
ligand 1, and cytotoxic T-lymphocyte-associated protein 4 provide deep and durable …

Multiparametric senescent cell phenotyping reveals targets of senolytic therapy in the aged murine skeleton

ML Doolittle, D Saul, J Kaur, JL Rowsey, SJ Vos… - Nature …, 2023 - nature.com
Senescence drives organismal aging, yet the deep characterization of senescent cells in
vivo remains incomplete. Here, we apply mass cytometry by time-of-flight using carefully …

Breast cancer diagnosis: Imaging techniques and biochemical markers

SH Jafari, Z Saadatpour… - Journal of cellular …, 2018 - Wiley Online Library
Breast cancer is a complex disease which is found as the second cause of cancer‐
associated death among women. Accumulating of evidence indicated that various factors …

Significance of CD44 and CD24 as cancer stem cell markers: an enduring ambiguity

A Jaggupilli, E Elkord - Journal of Immunology Research, 2012 - Wiley Online Library
Cancer stem cell population is a subset of cells capable of dictating invasion, metastasis,
heterogeneity, and therapeutic resistance in tumours. Eradication of this rare population is a …

[HTML][HTML] CD24+ liver tumor-initiating cells drive self-renewal and tumor initiation through STAT3-mediated NANOG regulation

TKW Lee, A Castilho, VCH Cheung, KH Tang, S Ma… - Cell stem cell, 2011 - cell.com
Tumor-initiating cells (T-ICs) are a subpopulation of chemoresistant tumor cells that have
been shown to cause tumor recurrence upon chemotherapy. Identification of T-ICs and their …

Diversity of immune checkpoints in cancer immunotherapy

Z Guo, R Zhang, AG Yang, G Zheng - Frontiers in Immunology, 2023 - frontiersin.org
Finding effective treatments for cancer remains a challenge. Recent studies have found that
the mechanisms of tumor evasion are becoming increasingly diverse, including abnormal …

Molecular definition of breast tumor heterogeneity

M Shipitsin, LL Campbell, P Argani, S Weremowicz… - Cancer cell, 2007 - cell.com
Cells with distinct phenotypes including stem-cell-like properties have been proposed to
exist in normal human mammary epithelium and breast carcinomas, but their detailed …